L.J. Altfest & Co’s VanEck Biotech ETF BBH Stock Holding History

L.J. Altfest & Co’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.6M	Sell	8,507 -106	-1%	-$20.4K	0.17%	103
2025 Q4	$1.63M	Sell	8,613 -239	-3%	-$44.2K	0.18%	95
2025 Q3	$1.47M	Buy	8,852 +322	+4%	+$52.5K	0.16%	96
2025 Q2	$1.31M	Buy	8,530 +869	+11%	+$129K	0.15%	104
2025 Q1	$1.21M	Buy	7,661 +1,007	+15%	+$163K	0.15%	110
2024 Q4	$1.04M	Sell	6,654 -94	-1%	-$15.8K	0.13%	109
2024 Q3	$1.2M	Buy	6,748 +66	+1%	+$11.7K	0.16%	109
2024 Q2	$1.13M	Sell	6,682 -1,213	-15%	-$198K	0.15%	103
2024 Q1	$1.31M	Buy	7,895 +319	+4%	+$52.8K	0.19%	91
2023 Q4	$1.25M	Sell	7,576 -81	-1%	-$12.5K	0.18%	100
2023 Q3	$1.19M	Buy	7,657 +274	+4%	+$43.8K	0.19%	92
2023 Q2	$1.15M	Buy	7,383 +319	+5%	+$51K	0.17%	93
2023 Q1	$1.15M	Sell	7,064 -14,121	-67%	-$2.28M	0.18%	84
2022 Q4	$3.38M	Buy	21,185 +15,591	+279%	+$2.47M	0.56%	36
2022 Q3	$788K	Buy	+5,594	New	+$846K	0.15%	102

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

L.J. Altfest & Co's BBH Position: Q1 2026 in Review

L.J. Altfest & Co reduced its VanEck Biotech ETF (BBH) stake by 1.2% in Q1 2026, selling an estimated $20.4K and leaving 8,507 shares worth $1.6M. The position accounts for 0.17% of the portfolio, ranked #103.

L.J. Altfest & Co first reported a position in BBH in Q3 2022 and has held it in 15 quarters since. The position peaked at $3.38M in Q4 2022. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

L.J. Altfest & Co held 8,507 shares of VanEck Biotech ETF worth $1.6M as of Q1 2026.
L.J. Altfest & Co sold 106 VanEck Biotech ETF shares in Q1 2026, an estimated $20.4K.
VanEck Biotech ETF made up 0.17% of L.J. Altfest & Co's portfolio in Q1 2026, its #103 holding.
L.J. Altfest & Co first reported a position in VanEck Biotech ETF in Q3 2022 and has held it in 15 quarters since.
L.J. Altfest & Co's VanEck Biotech ETF position peaked at $3.38M in Q4 2022.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on L.J. Altfest & Co's 13F filing for Q1 2026, filed 28 Apr 2026.